Literature DB >> 10869803

Similar levels of long-term potentiation in amyloid precursor protein -null and wild-type mice in the CA1 region of picrotoxin treated slices.

S M Fitzjohn1, R A Morton, F Kuenzi, C H Davies, G R Seabrook, G L Collingridge.   

Abstract

Although mutations in amyloid precursor protein (APP) are known to be involved in the development of Alzheimer's disease in some individuals, the role of this protein in normal brain function is poorly understood. We have reported previously that in APP-null mice long-term potentiation (LTP) in the CA1 region of the hippocampus is present but its magnitude is reduced compared to wild-type littermate controls. In the present study, we have confirmed this deficit using a different theta burst induction protocol. Significantly, however, we find that this deficit is no longer apparent when LTP experiments are performed following blockade of gamma-aminobutyric acid(A) receptors. These results suggest that the LTP process per se is not altered by the absence of APP. The deficit may therefore be an indirect consequence of other changes in the hippocampus that occur in the APP-null animal.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10869803     DOI: 10.1016/s0304-3940(00)01204-0

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  21 in total

1.  Glial protein S100B modulates long-term neuronal synaptic plasticity.

Authors:  Hiroshi Nishiyama; Thomas Knopfel; Shogo Endo; Shigeyoshi Itohara
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

2.  Functional consequences of the lack of amyloid precursor protein in the mouse dentate gyrus in vivo.

Authors:  Peter Jedlicka; Mirka Owen; Matej Vnencak; Jakob-A Tschäpe; Meike Hick; Ulrike C Müller; Thomas Deller
Journal:  Exp Brain Res       Date:  2011-11-11       Impact factor: 1.972

Review 3.  Synaptic plasticity in animal models of early Alzheimer's disease.

Authors:  Michael J Rowan; Igor Klyubin; William K Cullen; Roger Anwyl
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2003-04-29       Impact factor: 6.237

Review 4.  The role of APP and APLP for synaptic transmission, plasticity, and network function: lessons from genetic mouse models.

Authors:  Martin Korte; Ulrike Herrmann; Xiaomin Zhang; Andreas Draguhn
Journal:  Exp Brain Res       Date:  2011-10-18       Impact factor: 1.972

5.  The proteins of human chromosome 21.

Authors:  Katheleen Gardiner; Alberto C S Costa
Journal:  Am J Med Genet C Semin Med Genet       Date:  2006-08-15       Impact factor: 3.908

6.  APP and APLP2 are essential at PNS and CNS synapses for transmission, spatial learning and LTP.

Authors:  Sascha W Weyer; Maja Klevanski; Andrea Delekate; Vootele Voikar; Dorothee Aydin; Meike Hick; Mikhail Filippov; Natalia Drost; Kristin L Schaller; Martina Saar; Miriam A Vogt; Peter Gass; Ayan Samanta; Andres Jäschke; Martin Korte; David P Wolfer; John H Caldwell; Ulrike C Müller
Journal:  EMBO J       Date:  2011-04-26       Impact factor: 11.598

7.  Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer's disease.

Authors:  K T Dineley; M Westerman; D Bui; K Bell; K H Ashe; J D Sweatt
Journal:  J Neurosci       Date:  2001-06-15       Impact factor: 6.167

Review 8.  Presenilins and APP in neuritic and synaptic plasticity: implications for the pathogenesis of Alzheimer's disease.

Authors:  Sic L Chan; Katsutoshi Furukawa; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

9.  Age-related impairment of synaptic transmission but normal long-term potentiation in transgenic mice that overexpress the human APP695SWE mutant form of amyloid precursor protein.

Authors:  S M Fitzjohn; R A Morton; F Kuenzi; T W Rosahl; M Shearman; H Lewis; D Smith; D S Reynolds; C H Davies; G L Collingridge; G R Seabrook
Journal:  J Neurosci       Date:  2001-07-01       Impact factor: 6.167

Review 10.  Estrogen and Alzheimer's disease: the story so far.

Authors:  Brenna Cholerton; Carey E Gleason; Laura D Baker; Sanjay Asthana
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.